Search research articles
Contact Us
Filters
Showing results (1241-1250 of 1,434) with videos related to
Page
of 144
Sort By:
Cancer Immunology Research
|
October 1, 2016
Systemic GM-CSF Recruits Effector T Cells into the Tumor Microenvironment in Localized Prostate Cancer
Xiao X Wei, Stephen Chan, Serena Kwek, et al.
The Journal of Molecular Diagnostics : JMD
|
March 6, 2016
Application of a Clinical Whole-Transcriptome Assay for Staging and Prognosis of Prostate Cancer Diagnosed in Needle Core Biopsy Specimens
Beatrice S Knudsen, Hyung L Kim, Nicholas Erho, et al.
Cancer Epidemiology
|
September 25, 2021
Analgesic use and the risk of renal cell carcinoma - Findings from the Consortium for the Investigation of Renal Malignancies (CONFIRM) study
F J Bruinsma, S Jordan, J K Bassett, et al.
Headache
|
October 15, 2025
The contribution of lumbar puncture opening pressure in the diagnosis of spontaneous intracranial hypotension: A systematic literature review and meta-analysis
Simy K Parikh, Constance R Deline, Morgan McCreary, et al.
The Journal of Urology
|
February 26, 2021
A Phase 2/3 Prospective Multicenter Study of the Diagnostic Accuracy of Prostate Specific Membrane Antigen PET/CT with <sup>18</sup>F-DCFPyL in Prostate Cancer Patients (OSPREY)
Kenneth J Pienta, Michael A Gorin, Steven P Rowe, et al.
European Urology Oncology
|
August 15, 2019
Genomic Risk Predicts Molecular Imaging-detected Metastatic Nodal Disease in Prostate Cancer
Melody J Xu, Zachary Kornberg, Adam J Gadzinski, et al.
Molecular Cancer Therapeutics
|
April 8, 2010
Bridging the gap between cytotoxic and biologic therapy with metronomic topotecan and pazopanib in ovarian cancer
William M Merritt, Alpa M Nick, Amy R Carroll, et al.
European Urology
|
February 14, 2018
Role of Surveillance Biopsy with No Cancer as a Prognostic Marker for Reclassification: Results from the Canary Prostate Active Surveillance Study
James T Kearns, Anna V Faino, Lisa F Newcomb, et al.
European Urology
|
March 31, 2015
Precision Medicine in Active Surveillance for Prostate Cancer: Development of the Canary-Early Detection Research Network Active Surveillance Biopsy Risk Calculator
Donna P Ankerst, Jing Xia, Ian M Thompson, et al.
Annals of Internal Medicine
|
November 29, 2017
Comparative Analysis of Biopsy Upgrading in Four Prostate Cancer Active Surveillance Cohorts
Lurdes Y T Inoue, Daniel W Lin, Lisa F Newcomb, et al.
Page
of 144
Search research articles
Search
Showing results (1241-1250 of 1,434) with videos related to
Sort By:
Page
of 144
Cancer Immunology Research
|
October 1, 2016
Systemic GM-CSF Recruits Effector T Cells into the Tumor Microenvironment in Localized Prostate Cancer
Xiao X Wei, Stephen Chan, Serena Kwek, et al.
The Journal of Molecular Diagnostics : JMD
|
March 6, 2016
Application of a Clinical Whole-Transcriptome Assay for Staging and Prognosis of Prostate Cancer Diagnosed in Needle Core Biopsy Specimens
Beatrice S Knudsen, Hyung L Kim, Nicholas Erho, et al.
Cancer Epidemiology
|
September 25, 2021
Analgesic use and the risk of renal cell carcinoma - Findings from the Consortium for the Investigation of Renal Malignancies (CONFIRM) study
F J Bruinsma, S Jordan, J K Bassett, et al.
Headache
|
October 15, 2025
The contribution of lumbar puncture opening pressure in the diagnosis of spontaneous intracranial hypotension: A systematic literature review and meta-analysis
Simy K Parikh, Constance R Deline, Morgan McCreary, et al.
The Journal of Urology
|
February 26, 2021
A Phase 2/3 Prospective Multicenter Study of the Diagnostic Accuracy of Prostate Specific Membrane Antigen PET/CT with <sup>18</sup>F-DCFPyL in Prostate Cancer Patients (OSPREY)
Kenneth J Pienta, Michael A Gorin, Steven P Rowe, et al.
European Urology Oncology
|
August 15, 2019
Genomic Risk Predicts Molecular Imaging-detected Metastatic Nodal Disease in Prostate Cancer
Melody J Xu, Zachary Kornberg, Adam J Gadzinski, et al.
Molecular Cancer Therapeutics
|
April 8, 2010
Bridging the gap between cytotoxic and biologic therapy with metronomic topotecan and pazopanib in ovarian cancer
William M Merritt, Alpa M Nick, Amy R Carroll, et al.
European Urology
|
February 14, 2018
Role of Surveillance Biopsy with No Cancer as a Prognostic Marker for Reclassification: Results from the Canary Prostate Active Surveillance Study
James T Kearns, Anna V Faino, Lisa F Newcomb, et al.
European Urology
|
March 31, 2015
Precision Medicine in Active Surveillance for Prostate Cancer: Development of the Canary-Early Detection Research Network Active Surveillance Biopsy Risk Calculator
Donna P Ankerst, Jing Xia, Ian M Thompson, et al.
Annals of Internal Medicine
|
November 29, 2017
Comparative Analysis of Biopsy Upgrading in Four Prostate Cancer Active Surveillance Cohorts
Lurdes Y T Inoue, Daniel W Lin, Lisa F Newcomb, et al.
Page
of 144